GRACEcast
Expert oncologists provide brief, distilled summaries of the most central issues in cancer management and emerging approaches for patients and caregivers. The Global Resource for Advancing Cancer Education (GRACE) is committed to providing the knowledge that will help enable the general public to be informed participants in their own care. Visit cancerGRACE.org for more info.

Dr. Jared Weiss from the University of North Carolina, Chapel Hill reviews results from HPV-positive patients with head and neck cancer (HNSCC) from recent trials and describes emerging research in this population.

Direct download: GRACEcast-158_HeadNeck-Video_HPV_HNSCC_Clinical_Trials.m4v
Category:Head-Neck-Video -- posted at: 1:41pm PDT

Dr. Jared Weiss from the University of North Carolina, Chapel Hill reviews results from HPV-positive patients with head and neck cancer (HNSCC) from recent trials and describes emerging research in this population.

Direct download: GRACEcast-158_HeadNeck-Audio_HPV_HNSCC_Clinical_Trials.mp3
Category:Head-Neck-Audio -- posted at: 1:41pm PDT

Dr. Jared Weiss from the University of North Carolina, Chapel Hill introduces us to the human papilloma virus and its role as a cause and relevant prognostic factor for head and neck cancer (HNSCC).

Direct download: GRACEcast-157_HeadNeck-Video_HPV_Introduction_HNSCC_Weiss.m4v
Category:Head-Neck-Video -- posted at: 1:40pm PDT

GRACE, cancerGRACE, GRACEcast, Jared Weiss, Unveristy of North Carolina-Chapel Hill, UNC-Chapel Hill, induction therapy, neoadjuvant therapy, head and neck cancer, HNSCC, carbplatin, paclitaxel, cetuximab, Taxol, Erbitux, weekly

Direct download: GRACEcast-157_HeadNeck-Audio_HPV_Introduction_HNSCC_Weiss.mp3
Category:Head-Neck-Audio -- posted at: 1:40pm PDT